Bruno Bouça Marisa Roldão Paula Bogalho Luís Cerqueira José Silva-Nunes
10.3389/fendo.2022.889074
Front Endocrinol (Lausanne)
2022 May 4;13:889074.
covid-19 case report diabetes insipidus mrna vaccine
CC BY
https://pubmed.ncbi.nlm.nih.gov/35600593/
COVID-19 / prevention & control Diabetes Insipidus, Neurogenic / complications Diabetes Insipidus, Neurogenic / etiology Diabetes Mellitus Hypophysitis / complications
COVID-19 / prevention & control Diabetes Insipidus, Neurogenic / complications Diabetes Insipidus, Neurogenic / etiology Diabetes Mellitus Hypophysitis / complications Case Reports Adult BNT162 Vaccine COVID-19 Vaccines / adverse effects Female Humans Immunization / adverse effects RNA, Messenger COVID-19 Vaccines RNA, Messenger BNT162 Vaccine
PMC9114295
35600593
Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report
2022